A Democratic bill with 1 Republican cosponsor · See all 2 cosponsors
Last activity — Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
In committee
Introduced and handed to a committee in the chamber it started in.
The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.
Its path through Congress
- Introduced
- In Committee
What this bill would do
This bill, known as the "Reducing Drug Prices for Seniors Act," seeks to amend the Social Security Act regarding Medicare Part D. It changes how coinsurance is calculated for covered drugs. Instead of using the wholesale acquisition cost, the bill requires coinsurance to be based on the drug's actual acquisition cost when that cost is lower. This change would apply to plan years starting on or after January 1, 2026. The actual acquisition cost is defined as the negotiated price net of any manufacturer-provided price concessions.
Yes· 3 of 14
- Scored +7
Would people over 65 be better off under this?
The bill directly lowers out-of-pocket prescription drug costs for seniors through the Medicare Part D program.
- Scored +7
Would retired people be better off under this?
The bill lowers the cost of prescription drugs for retirees enrolled in Medicare Part D.
- Scored +7
Does this lower the price of prescription medicines?
The bill reduces out-of-pocket drug costs for seniors by calculating coinsurance based on the drug's actual acquisition cost rather than the higher wholesale price.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Lower Coinsurance Amounts: For plan years beginning on or after January 1, 2026, coinsurance for covered Part D drugs will be calculated based on the actual acquisition cost if it is lower than the wholesale acquisition cost. This is considered positive because it changes the basis of the calculation for costs above the annual deductible and below the out-of-pocket threshold. (Section 2, subsection (b)(10)(A))
-
Clearer Definition of Cost: The bill defines "actual acquisition cost" as the negotiated price of the drug under the plan, net of any manufacturer-provided price concessions, as reported in the Detailed DIR Report. (Section 2, subsection (b)(10)(B))
Potential Negative Impacts for People
- No negative impacts are explicitly stated in the text provided.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Tap or hover a score for the reason it gave.
- Demographic And Interest Groups
- Would retired people be better off under this? — The bill lowers the cost of prescription drugs for retirees enrolled in Medicare Part D. Would people over 65 be better off under this? — The bill directly lowers out-of-pocket prescription drug costs for seniors through the Medicare Part D program. Would households on low incomes be better off under this? — Seniors with low incomes will benefit from the reduction in drug coinsurance costs. Would Black Americans be better off under this? — The bill provides financial relief on prescription drugs for all seniors, including Black Americans. Would Asian Americans be better off under this? — The bill provides financial relief on prescription drugs for all seniors, including Asian Americans. Would Hispanic Americans be better off under this? — The bill provides financial relief on prescription drugs for all seniors, including Hispanic Americans. Would middle-income households be better off under this? — Middle-income seniors will see a reduction in their prescription drug expenses. Would Native Americans be better off under this? — The bill provides financial relief on prescription drugs for all seniors, including Native Americans. Would white Americans be better off under this? — The bill provides financial relief on prescription drugs for all seniors, including white Americans.
- Healthcare
- Does this lower the price of prescription medicines? — The bill reduces out-of-pocket drug costs for seniors by calculating coinsurance based on the drug's actual acquisition cost rather than the higher wholesale price. Does this make health care easier to get in general? — Lower drug costs may improve financial access to necessary medications for those on Medicare. Does this put more money into Medicare, the health coverage for people over 65? — The bill effectively increases the value of Medicare Part D benefits by basing coinsurance on lower actual acquisition costs.
- Social Issues And Justice
- Does this strengthen Social Security? — The bill provides financial relief to individuals relying on Medicare, which is a central component of the social safety net for seniors.
- Economy And Finance
- Is this likely to grow the economy? — By basing drug costs on actual acquisition prices, the bill may marginally increase consumer purchasing power.
- 10/17/2025
- 1 Cosponsor added.
- 2/12/2025
- Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 1 Cosponsor added.
- Introduced in House
One bill Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.
Josh HarderDemocrat · California
August PflugerRepublican · Texas